August 9, 2024 - EverGlade Consulting

August 9, 2024

host-directed-therapeutics

JPM & JPEO Issues RFI for Host-Directed Therapeutics for Prophylaxis

Leave a Comment / EverGlade Insights, JPEO / By

Evaluation Criteria White Paper Template W911SR-24-S-HDTX+RFI The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), along with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), invites stakeholders from industry, academia, and nonprofit sectors to submit white papers for the development and repurposing of host-directed therapeutics. […]

JPM & JPEO Issues RFI for Host-Directed Therapeutics for Prophylaxis Read More »

A closeup shot of a scientist conducting the gel electrophoresis biological process as part of coronavirus research

BARDA Announces Request for Project Proposals for Small Molecule Drugs

Leave a Comment / BARDA, EverGlade Insights / By

BARDA RRPV 24-03-SmMol The Biomedical Advanced Research and Development Authority (BARDA) has released a Request for Project Proposals (RPP) under the Rapid Response Partnership Vehicle (RRPV) for developing small molecule therapeutics aimed at COVID-19 Pre-exposure Prophylaxis (PrEP). This initiative enhances national health security by advancing medical countermeasures against SARS-CoV-2 and future health threats. BARDA’s call

BARDA Announces Request for Project Proposals for Small Molecule Drugs Read More »

Scroll to Top